3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
4
Neurofibroma, Plexiform
2
Neoplasms
2
Pancreatic Neoplasms
1
Pain
1
Neurofibrosarcoma
1
Melanoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Nivolumab
3
ulixertinib
2
binimetinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cetuximab
2
CTLA-4 Antigen
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
temsirolimus
1
selpercatinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
AZD 6244
×
30 days
×
Clear all
No trials found.